“…Different structural types of thiazoloindoles are identified as cyclin-dependent kinase II inhibitor to prevent/reduce the severity of epithelial cell toxicity. [7] Several structural types of thiazoloindoles can be distinguished with regard to the position of the fusion between thiazole, benzene, and pyrrole rings. Among them, five selected types of thiazoloindoles, i. e. thiazolo[3,2-a]-, [8] -[3,4-a]-, [9] - [5,4-b]-, [10] -[5,4-e]-, [11] and -[4,5e]indoles [12] have been reported.…”